European Organisation For Research & Treatment Of Cancer
🇬🇧United Kingdom
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer
Phase 1
Completed
- Conditions
- Transitional Cell Cancer of the Renal Pelvis and UreterBladder Cancer
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2014-07-01
- Target Recruit Count
- 18
- Registration Number
- NCT00623064
- Locations
- 🇩🇰
Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Phase 2
Completed
- Conditions
- Endometrial CancerHead and Neck CancerMelanoma (Skin)Breast CancerOvarian CancerSarcoma
- First Posted Date
- 2007-09-10
- Last Posted Date
- 2013-10-07
- Target Recruit Count
- 76
- Registration Number
- NCT00526149
- Locations
- 🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
Phase 1
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2007-08-15
- Last Posted Date
- 2015-02-10
- Target Recruit Count
- 28
- Registration Number
- NCT00516607
- Locations
- 🇬🇧
Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase 1
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2018-07-09
- Target Recruit Count
- 7
- Registration Number
- NCT00498953
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Phase 2
Completed
- Conditions
- Malignant Mesothelioma
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2018-07-12
- Target Recruit Count
- 82
- Registration Number
- NCT00458913
- Locations
- 🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-03-22
- Last Posted Date
- 2016-07-07
- Target Recruit Count
- 129
- Registration Number
- NCT00450892
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷CHRU de Limoges, Limoges, France
🇫🇷Centre Leon Berard, Lyon, France
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Completed
- Conditions
- Cancer
- First Posted Date
- 2007-03-09
- Last Posted Date
- 2018-02-01
- Target Recruit Count
- 304
- Registration Number
- NCT00445952
- Locations
- 🇩🇪
German Hodgkin's Lymphoma Study Group, Cologne, Germany
🇫🇷CHU de Grenoble - Hopital de la Tronche, Grenoble, France
🇮🇹Ospedale San Martino, Genoa, Italy
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2
- Conditions
- Colorectal CancerMetastatic Cancer
- First Posted Date
- 2007-02-22
- Last Posted Date
- 2011-09-02
- Target Recruit Count
- 100
- Registration Number
- NCT00438737
- Locations
- 🇫🇷
Hopital Ambroise Pare, Boulogne, France
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
Phase 3
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2022-11-17
- Target Recruit Count
- 6600
- Registration Number
- NCT00433589
- Locations
- 🇳🇱
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
Phase 3
- Conditions
- Lymphoma
- Interventions
- Drug: ABVD q4 weeksDrug: BEACOPP escalated q3 weeksProcedure: FDG-PET scanRadiation: IN-RT 30 Gy (+ boost 6 Gy residual)
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2021-02-03
- Target Recruit Count
- 1952
- Registration Number
- NCT00433433
- Locations
- 🇳🇱
Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath